|
1
|
Karakike E, Adami ME, Lada M, Gkavogianni
T, Koutelidakis IM, Bauer M, Giamarellos-Bourboulis EJ and
Tsangaris I: Late peaks of HMGB1 and sepsis outcome evidence for
synergy with chronic inflammatory disorders. Shock. 52:334–339.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stengel S, Quickert S, Lutz P, Ibidapo-Obe
O, Steube A, Köse-Vogel N, Yarbakht M, Reuken PA, Busch M, Brandt
A, et al: Peritoneal level of CD206 associates with mortality and
an inflammatory macrophage phenotype in patients with decompensated
cirrhosis and spontaneous bacterial peritonitis. Gastroenterology.
158:1745–1761. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rajaiah R, Perkins DJ, Ireland DD and
Vogel SN: CD14 dependence of TLR4 endocytosis and TRIF signaling
displays ligand specificity and is dissociable in endotoxin
tolerance. Proc Natl Acad Sci USA. 112:8391–8396. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng
J, Li Y, Wang X and Zhao L: Inflammatory responses and
inflammation-associated diseases in organs. Oncotarget.
9:7204–7218. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pizzuto M, Lonez C, Baroja-Mazo A,
Martínez-Banaclocha H, Tourlomousis P, Gangloff M, Pelegrin P,
Ruysschaert JM, Gay NJ and Bryant CE: Saturation of acyl chains
converts cardiolipin from an antagonist to an activator of
Toll-like receptor-4. Cell Mol Life Sci. 76:3667–3678. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Taniguchi K and Karin M: NF-κB,
inflammation, immunity and cancer: Coming of age. Nat Rev Immunol.
18:309–324. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Obaid M, Udden SMN, Deb P, Shihabeddin N,
Zaki MH and Mandal SS: LncRNA HOTAIR regulates
lipopolysaccharide-induced cytokine expression and inflammatory
response in macrophages. Sci Rep. 8:156702018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aoki T, Frȍsen J, Fukuda M, Bando K, Shioi
G, Tsuji K, Ollikainen E, Nozaki K, Laakkonen J and Narumiya S:
Prostaglandin E2-EP2-NF-κB signaling in macrophages as a potential
therapeutic target for intracranial aneurysms. Sci Signal.
10:eaah60372017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Manček-Keber M, Gradišar H, Iñigo Pestaña
M, Martinez de Tejada G and Jerala R: Free thiol group of MD-2 as
the target for inhibition of the lipopolysaccharide-induced cell
activation. J Biol Chem. 284:19493–19500. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Shan X, Dai Y, Jiang L, Chen G,
Zhang Y, Wang Z, Dong L, Wu J, Guo G, et al: Curcumin analog L48H37
prevents lipopolysaccharide-induced TLR4 signaling pathway
activation and sepsis via targeting MD2. J Pharmacol Exp Ther.
353:539–550. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kocaadam B and Şanlier N: Curcumin, an
active component of turmeric (Curcuma longa), and its
effects on health. Crit Rev Food Sci Nutr. 57:2889–2895. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Akter J, Hossain MA, Takara K, Islam MZ
and Hou DX: Antioxidant activity of different species and varieties
of turmeric (Curcuma spp): Isolation of active compounds.
Comp Biochem Physiol C Toxicol Pharmacol. 215:9–17. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park SY and Kim DS: Discovery of natural
products from Curcuma longa that protect cells from
beta-amyloid insult: A drug discovery effort against Alzheimer's
disease. J Nat Prod. 65:1227–1231. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chuprajob T, Changtam C, Chokchaisiri R,
Chunglok W, Sornkaew N and Suksamrarn A: Synthesis, cytotoxicity
against human oral cancer KB cells and structure-activity
relationship studies of trienone analogues of curcuminoids. Bioorg
Med Chem Lett. 24:2839–2844. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang R, Zhang X, Chen C, Chen G, Zhong Q,
Zhang Q, Zheng S, Wang G and Chen QH: Synthesis and evaluation of
1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based
anticancer agents. Eur J Med Chem. 110:164–180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Utaipan T, Boonyanuphong P, Chuprajob T,
Suksamrarn A and Chunglok W: A trienone analog of curcumin, 1,7-bis
(3-hydroxyphenyl)-1,4,6-heptatrien-3-one, possesses ROS- and
caspase-mediated apoptosis in human oral squamous cell carcinoma
cells in vitro. Appl Biol Chem. 63:72020. View Article : Google Scholar
|
|
17
|
Srivilai J, Rabgay K, Khorana N, Waranuch
N, Nuengchamnong N, Wisuitiprot W, Chuprajob T, Changtam C,
Suksamrarn A, Chavasiri W, et al: Anti-androgenic curcumin
analogues as steroid 5-alpha reductase inhibitors. Med Chem Res.
26:1550–1556. 2017. View Article : Google Scholar
|
|
18
|
Jang MK, Sohn DH and Ryu JH: A curcuminoid
and sesquiterpenes as inhibitors of macrophage TNF-α release from
Curcuma zedoaria. Planta Med. 67:550–552. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tan RZ, Liu J, Zhang YY, Wang HL, Li JC,
Liu YH, Zhong X, Zhang YW, Yan Y, Lan HY, et al: Curcumin relieved
cisplatin-induced kidney inflammation through inhibiting
Mincle-maintained M1 macrophage phenotype. Phytomedicine.
52:284–294. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao F, Gong Y, Hu Y, Lu M, Wang J, Dong
J, Chen D, Chen L, Fu F and Qiu F: Curcumin and its major
metabolites inhibit the inflammatory response induced by
lipopolysaccharide: Translocation of nuclear factor-κB as potential
target. Mol Med Rep. 11:3087–3093. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gradišar H, Keber MM, Pristovšek P and
Jerala R: MD-2 as the target of curcumin in the inhibition of
response to LPS. J Leukoc Biol. 82:968–974. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mirzaei H, Shakeri A, Rashidi B, Jalili A,
Banikazemi Z and Sahebkar A: Phytosomal curcumin: A review of
pharmacokinetic, experimental and clinical studies. Biomed
Pharmacother. 85:102–112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koeberle A, Muñoz E, Appendino GB, Minassi
A, Pace S, Rossi A, Weinigel C, Barz D, Sautebin L, Caprioglio D,
et al: SAR studies on curcumin's pro-inflammatory targets:
Discovery of prenylated pyrazolocurcuminoids as potent and
selective novel inhibitors of 5-lipoxygenase. J Med Chem.
57:5638–5648. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Changtam C, de Koning HP, Ibrahim H, Sajid
MS, Gould MK and Suksamrarn A: Curcuminoid analogs with potent
activity against Trypanosoma and Leishmania species.
Eur J Med Chem. 45:941–956. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun J, Zhang X, Broderick M and Fein H:
Measurement of nitric oxide production in biological systems by
using Griess reaction assay. Sensors (Basel). 3:276–284. 2003.
View Article : Google Scholar
|
|
26
|
Morris GM, Huey R, Lindstrom W, Sanner MF,
Belew RK, Goodsell DS and Olson AJ: AutoDock4 and AutoDockTools4:
Automated docking with selective receptor flexibility. J Comput
Chem. 30:2785–2791. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Morris G, Goodsell D, Halliday R, Huey R,
Hart W, Belew R and Olson A: Automated docking using a lamarckian
genetic algorithm and an empirical binding free energy function. J
Comput Chem. 19:1639–1662. 1998. View Article : Google Scholar
|
|
28
|
Case DA, Betz RM, Cerutti DS, Cheatham TE,
Darden TA, Duke RE, Giese TJ, Gohlke H, Goetz AW, Homeyer N, et al:
AMBER 2016. University of California; San Francisco: 2016
|
|
29
|
Liang G, Li X, Chen L, Yang S, Wu X,
Studer E, Gurley E, Hylemon PB, Ye F, Li Y, et al: Synthesis and
anti-inflammatory activities of mono-carbonyl analogues of
curcumin. Bioorg Med Chem Lett. 18:1525–1529. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao C, Zhang Y, Zou P, Wang J, He W, Shi
D, Li H, Liang G and Yang S: Synthesis and biological evaluation of
a novel class of curcumin analogs as anti-inflammatory agents for
prevention and treatment of sepsis in mouse model. Drug Des Devel
Ther. 9:1663–1678. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ullah MO, Sweet MJ, Mansell A, Kellie S
and Kobe B: TRIF-dependent TLR signaling, its functions in host
defense and inflammation, and its potential as a therapeutic
target. J Leukoc Biol. 100:27–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Z, Chen G, Chen L, Liu X, Fu W, Zhang
Y, Li C, Liang G and Cai Y: Insights into the binding mode of
curcumin to MD-2: Studies from molecular docking, molecular
dynamics simulations and experimental assessments. Mol Biosyst.
11:1933–1938. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Y, Shan X, Chen G, Jiang L, Wang Z,
Fang Q, Liu X, Wang J, Zhang Y, Wu W, et al: MD-2 as the target of
a novel small molecule, L6H21, in the attenuation of LPS-induced
inflammatory response and sepsis. Br J Pharmacol. 172:4391–4405.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Y, Liu Z, Wu J, Bai B, Chen H, Xiao
Z, Chen L, Zhao Y, Lum H, Wang Y, et al: New MD2 inhibitors derived
from curcumin with improved anti-inflammatory activity. Eur J Med
Chem. 148:291–305. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li B, Hu Y, Zhao Y, Cheng M, Qin H, Cheng
T, Wang Q, Peng X and Zhang X: Curcumin attenuates titanium
particle-induced inflammation by regulating macrophage polarization
in vitro and in vivo. Front Immunol. 8:552017.PubMed/NCBI
|
|
36
|
Zhang J, Zheng Y, Luo Y, Du Y, Zhang X and
Fu J: Curcumin inhibits LPS-induced neuroinflammation by promoting
microglial M2 polarization via TREM2/TLR4/NF-κB pathways in BV2
cells. Mol Immunol. 116:29–37. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Oh SW, Cha JY, Jung JE, Chang BC, Kwon HJ,
Lee BR and Kim DY: Curcumin attenuates allergic airway inflammation
and hyper-responsiveness in mice through NF-κB inhibition. J
Ethnopharmacol. 136:414–421. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen Q, Chen T, Li W, Zhang W, Zhu J, Li
Y, Huang Y, Shen Y and Yu C: Mycoepoxydiene inhibits
lipopolysaccharide-induced inflammatory responses through the of
TRAF6 polyubiquitination. PLoS One. 7:e448902012. View Article : Google Scholar : PubMed/NCBI
|
